Copyright Reports & Markets. All rights reserved.

Global Leber's Hereditary Optic Neuropathy Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Leber's Hereditary Optic Neuropathy Drug

      • 1.1 Definition of Leber's Hereditary Optic Neuropathy Drug
      • 1.2 Leber's Hereditary Optic Neuropathy Drug Segment by Type
        • 1.2.1 Global Leber's Hereditary Optic Neuropathy Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Elamipretide
        • 1.2.3 GS-011
        • 1.2.4 IXC-201
        • 1.2.5 KH-176
        • 1.2.6 Others
      • 1.3 Leber's Hereditary Optic Neuropathy Drug Segment by Applications
        • 1.3.1 Global Leber's Hereditary Optic Neuropathy Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Leber's Hereditary Optic Neuropathy Drug Overall Market
        • 1.4.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue (2014-2025)
        • 1.4.2 Global Leber's Hereditary Optic Neuropathy Drug Production (2014-2025)
        • 1.4.3 North America Leber's Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Leber's Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)
        • 1.4.5 China Leber's Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Leber's Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Leber's Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)
        • 1.4.8 India Leber's Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Leber's Hereditary Optic Neuropathy Drug
      • 2.3 Manufacturing Process Analysis of Leber's Hereditary Optic Neuropathy Drug
      • 2.4 Industry Chain Structure of Leber's Hereditary Optic Neuropathy Drug

      3 Development and Manufacturing Plants Analysis of Leber's Hereditary Optic Neuropathy Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Leber's Hereditary Optic Neuropathy Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Leber's Hereditary Optic Neuropathy Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Leber's Hereditary Optic Neuropathy Drug Production and Capacity Analysis
      • 4.2 Leber's Hereditary Optic Neuropathy Drug Revenue Analysis
      • 4.3 Leber's Hereditary Optic Neuropathy Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Leber's Hereditary Optic Neuropathy Drug Regional Market Analysis

      • 5.1 Leber's Hereditary Optic Neuropathy Drug Production by Regions
        • 5.1.1 Global Leber's Hereditary Optic Neuropathy Drug Production by Regions
        • 5.1.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Regions
      • 5.2 Leber's Hereditary Optic Neuropathy Drug Consumption by Regions
      • 5.3 North America Leber's Hereditary Optic Neuropathy Drug Market Analysis
        • 5.3.1 North America Leber's Hereditary Optic Neuropathy Drug Production
        • 5.3.2 North America Leber's Hereditary Optic Neuropathy Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Leber's Hereditary Optic Neuropathy Drug Import and Export
      • 5.4 Europe Leber's Hereditary Optic Neuropathy Drug Market Analysis
        • 5.4.1 Europe Leber's Hereditary Optic Neuropathy Drug Production
        • 5.4.2 Europe Leber's Hereditary Optic Neuropathy Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Leber's Hereditary Optic Neuropathy Drug Import and Export
      • 5.5 China Leber's Hereditary Optic Neuropathy Drug Market Analysis
        • 5.5.1 China Leber's Hereditary Optic Neuropathy Drug Production
        • 5.5.2 China Leber's Hereditary Optic Neuropathy Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Leber's Hereditary Optic Neuropathy Drug Import and Export
      • 5.6 Japan Leber's Hereditary Optic Neuropathy Drug Market Analysis
        • 5.6.1 Japan Leber's Hereditary Optic Neuropathy Drug Production
        • 5.6.2 Japan Leber's Hereditary Optic Neuropathy Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Leber's Hereditary Optic Neuropathy Drug Import and Export
      • 5.7 Southeast Asia Leber's Hereditary Optic Neuropathy Drug Market Analysis
        • 5.7.1 Southeast Asia Leber's Hereditary Optic Neuropathy Drug Production
        • 5.7.2 Southeast Asia Leber's Hereditary Optic Neuropathy Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Leber's Hereditary Optic Neuropathy Drug Import and Export
      • 5.8 India Leber's Hereditary Optic Neuropathy Drug Market Analysis
        • 5.8.1 India Leber's Hereditary Optic Neuropathy Drug Production
        • 5.8.2 India Leber's Hereditary Optic Neuropathy Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Leber's Hereditary Optic Neuropathy Drug Import and Export

      6 Leber's Hereditary Optic Neuropathy Drug Segment Market Analysis (by Type)

      • 6.1 Global Leber's Hereditary Optic Neuropathy Drug Production by Type
      • 6.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type
      • 6.3 Leber's Hereditary Optic Neuropathy Drug Price by Type

      7 Leber's Hereditary Optic Neuropathy Drug Segment Market Analysis (by Application)

      • 7.1 Global Leber's Hereditary Optic Neuropathy Drug Consumption by Application
      • 7.2 Global Leber's Hereditary Optic Neuropathy Drug Consumption Market Share by Application (2014-2019)

      8 Leber's Hereditary Optic Neuropathy Drug Major Manufacturers Analysis

      • 8.1 Alkeus Pharmaceuticals, Inc.
        • 8.1.1 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
        • 8.1.2 Alkeus Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.1.3 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Biovista Inc.
        • 8.2.1 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
        • 8.2.2 Biovista Inc. Product Introduction, Application and Specification
        • 8.2.3 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 GenSight Biologics S.A.
        • 8.3.1 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
        • 8.3.2 GenSight Biologics S.A. Product Introduction, Application and Specification
        • 8.3.3 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Ixchel Pharma, LLC
        • 8.4.1 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
        • 8.4.2 Ixchel Pharma, LLC Product Introduction, Application and Specification
        • 8.4.3 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Khondrion BV
        • 8.5.1 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
        • 8.5.2 Khondrion BV Product Introduction, Application and Specification
        • 8.5.3 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Spark Therapeutics, Inc.
        • 8.6.1 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
        • 8.6.2 Spark Therapeutics, Inc. Product Introduction, Application and Specification
        • 8.6.3 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Stealth BioTherapeutics Inc.
        • 8.7.1 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
        • 8.7.2 Stealth BioTherapeutics Inc. Product Introduction, Application and Specification
        • 8.7.3 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served

      9 Development Trend of Analysis of Leber's Hereditary Optic Neuropathy Drug Market

      • 9.1 Global Leber's Hereditary Optic Neuropathy Drug Market Trend Analysis
        • 9.1.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Leber's Hereditary Optic Neuropathy Drug Regional Market Trend
        • 9.2.1 North America Leber's Hereditary Optic Neuropathy Drug Forecast 2019-2025
        • 9.2.2 Europe Leber's Hereditary Optic Neuropathy Drug Forecast 2019-2025
        • 9.2.3 China Leber's Hereditary Optic Neuropathy Drug Forecast 2019-2025
        • 9.2.4 Japan Leber's Hereditary Optic Neuropathy Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Leber's Hereditary Optic Neuropathy Drug Forecast 2019-2025
        • 9.2.6 India Leber's Hereditary Optic Neuropathy Drug Forecast 2019-2025
      • 9.3 Leber's Hereditary Optic Neuropathy Drug Market Trend (Product Type)
      • 9.4 Leber's Hereditary Optic Neuropathy Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Leber's Hereditary Optic Neuropathy Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Leber's Hereditary Optic Neuropathy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Leber's Hereditary Optic Neuropathy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leber's Hereditary Optic Neuropathy Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Leber's Hereditary Optic Neuropathy Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Leber's Hereditary Optic Neuropathy Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Alkeus Pharmaceuticals, Inc.
        Biovista Inc.
        GenSight Biologics S.A.
        Ixchel Pharma, LLC
        Khondrion BV
        Spark Therapeutics, Inc.
        Stealth BioTherapeutics Inc.
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Elamipretide
        GS-011
        IXC-201
        KH-176
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now